Literature DB >> 34141077

Novel CFTR Modulators for Treating Cystic Fibrosis.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34141077      PMCID： PMC8201489          DOI： 10.1021/acsmedchemlett.1c00260

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Gastrointestinal malignancy in cystic fibrosis.

Authors:  Natasha Emily Hough; Stephen James Chapman; William George Flight
Journal:  Paediatr Respir Rev       Date:  2020-04-09       Impact factor: 2.726

Review 2.  Entering the era of highly effective modulator therapies.

Authors:  Kavita Dave; Rebecca Dobra; Sandra Scott; Clare Saunders; Jess Matthews; Nicholas J Simmonds; Jane C Davies
Journal:  Pediatr Pulmonol       Date:  2021-02

Review 3.  Cystic fibrosis year in review 2019: Section 1 CFTR modulators.

Authors:  Adrienne P Savant; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2020-09-01

Review 4.  How to determine the mechanism of action of CFTR modulator compounds: A gateway to theranostics.

Authors:  Margarida D Amaral
Journal:  Eur J Med Chem       Date:  2020-11-05       Impact factor: 6.514

Review 5.  Challenges in the use of highly effective modulator treatment for cystic fibrosis.

Authors:  Kathleen J Ramos; Joseph M Pilewski; Jennifer L Taylor-Cousar
Journal:  J Cyst Fibros       Date:  2021-01-30       Impact factor: 5.482

Review 6.  Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.

Authors:  Julia Konrad; Ernst Eber; Vanessa Stadlbauer
Journal:  Paediatr Respir Rev       Date:  2020-12-24       Impact factor: 2.726
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.